Skip to Main Content

Speakers

Hear from the speakers at the cutting edge

Amy Abernethy, M.D, Ph.D.

Amy Abernethy, M.D, Ph.D.

President of Product Development and Chief Medical Officer, Verily

Jennifer Doudna, Ph.D.

Jennifer Doudna, Ph.D.

Nobel Laureate, Co-inventor of CRISPR Technology; President, Innovative Genomics Institute

Stephen Gillett

Stephen Gillett

Chief Executive Officer, Verily

Vinod Khosla

Vinod Khosla

Founder, Khosla Ventures

Priti Krishtel, J.D.

Priti Krishtel, J.D.

Co-Founder and Co-Executive Director, Initiative for Medicines, Access & Knowledge (I-MAK); 2022 MacArthur Fellow

Robert Nelsen

Robert Nelsen

Co-Founder and Managing Director, ARCH Venture Partners

Daniel O'Day

Daniel O’Day

Chairman of the Board of Directors and Chief Executive Officer, Gilead Sciences

Emily Whitehead

Emily Whitehead

Co-Founder of the Emily Whitehead Foundation

Vineeta Agarwala, M.D., Ph.D.

Vineeta Agarwala, M.D., Ph.D.

General Partner, Andreessen Horowitz

David Altshuler, M.D., Ph.D.

Sponsor Speaker

David Altshuler, M.D., Ph.D.

Executive Vice President, Global Research, and Chief Scientific Officer, Vertex Pharmaceuticals

Catherine Ames

Catherine Ames

Patient & Patient Advocate, writer of Daily Trojan’s “Chronically Catherine”

Jamy Ard, M.D.

Jamy Ard, M.D.

Professor, Wake Forest School of Medicine, and Co-director, Weight Management Center, Atrium Health Wake Forest Baptist

Alberto Ascherio, M.D., Dr.PH

Alberto Ascherio, M.D., Dr.PH

Professor of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health

Peter Bach, M.D.

Peter Bach, M.D.

Chief Medical Officer, DELFI Diagnostics

Jacqueline Barendregt

Jacqueline Barendregt

Chief Operating Officer, IDEA Pharma

Sumita Bhatta, M.D.

Sponsor Speaker

Sumita Bhatta, M.D.

Vice President, Oncology, Therapeutic Area Head, Amgen

Kirsten Bibbins-Domingo, M.D., Ph.D.

Kirsten Bibbins-Domingo, M.D., Ph.D.

Editor in Chief, JAMA; Professor of Epidemiology and Biostatistics, UCSF

Mark Bunnage, Ph.D.

Sponsor Speaker

Mark Bunnage, Ph.D.

SVP, Head of Research, Vertex Pharmaceuticals

Peter Chin-Hong, M.D.

Peter Chin-Hong, M.D.

Associate Dean and Professor, UCSF School of Medicine

Tina Clarke, Ph.D., MPH

Tina Clarke, Ph.D., MPH

VP, Epidemiology and Distinguished Scientist, GRAIL LLC

Joel Dudley, Ph.D.

Joel Dudley, Ph.D.

Partner, Innovation Endeavors

David Fajgenbaum, M.D., MSc

David Fajgenbaum, M.D., MSc

Co-founder, Every Cure; Director, CSTL, at the University of Pennsylvania

Donna Ginther, Ph.D.

Donna Ginther, Ph.D.

Roy A. Roberts & Regents Distinguished Professor of Economics, Director, Institute for Policy & Social Research, University of Kansas

Rayyan Gorashi, M.S.

Rayyan Gorashi, M.S.

Ph.D. Student, Bioengineering at UC San Diego

Paul Hastings

Paul Hastings

Chief Executive Officer and President, Nkarta

Thomas Insel, M.D.

Thomas Insel, M.D.

Executive Chair and Co-Founder, Vanna Health

Ruth Itzhaki, Ph.D.

Virtual Speaker

Ruth Itzhaki, Ph.D.

Visiting Professorial Fellow, University of Oxford; Professorial Fellow Emerita, University of Manchester

Carl June, M.D.

Carl June, M.D.

Professor, University of Pennsylvania

Pratap Khedkar

Sponsor Speaker

Pratap Khedkar

Chief Executive Officer, ZS

Betty Kim, M.D., Ph.D., FRCSC, FAIMBE

Betty Kim, M.D., Ph.D., FRCSC, FAIMBE

Professor of Neurosurgery, MD Anderson Cancer Center

Gautam Kollu

Gautam Kollu

CEO, D2G Oncology

Sofie Kleppner, Ph.D.

Sofie Kleppner, Ph.D.

Associate Vice Provost & Associate Dean for Postdoctoral Affairs, Stanford University

Connor Landgraf

Connor Landgraf

Co-founder & CEO, Eko Health

Noga Leviner

Sponsor Speaker

Noga Leviner

Co-founder & CEO, PicnicHealth

Xin Li, Ph.D.

Xin Li, Ph.D.

Professor, Department of Molecular Pathobiology, New York University

Robert Lustig, M.D., MSL

Robert Lustig, M.D., MSL

Emeritus Professor of Pediatrics, UCSF

William Pao, M.D., Ph.D.

Sponsor Speaker

William Pao, M.D., Ph.D.

Chief Development Officer and Executive Vice President, Pfizer

Amit Phull, M.D.

Sponsor Speaker

Amit Phull, M.D.

Medical Director and SVP of Strategy, Doximity

Vidya Raman-Tangella

Sponsor Speaker

Vidya Raman-Tangella

Chief Medical Officer, Teladoc Health

Rita Redberg, M.D., MSc

Rita Redberg, M.D., MSc

Cardiologist and Professor of Medicine at the University of California, San Francisco

Gregory A. Rippon, M.D.

Sponsor Speaker

Gregory A. Rippon, M.D.

Vice President and Chief Medical Partner, Neurology, Genentech

Camille Samuels

Camille Samuels

Partner, Venrock

Suchi Saria, Ph.D.

Suchi Saria, Ph.D.

CEO & Founder Bayesian Health, Inc. / Endowed Chair & AI Prof at Johns Hopkins

Surbhi Sarna

Surbhi Sarna

Group Partner, Y Combinator

Michel Sadelain, M.D., Ph.D.

Michel Sadelain, M.D., Ph.D.

Director, Center for Cellular Engineering, Memorial Sloan Kettering Cancer Center

Nigam Shah, MBBS, Ph.D.

Nigam Shah, MBBS, Ph.D.

Chief Data Scientist, Stanford Healthcare

Christi Shaw

Christi Shaw

Life Science Leader, Patient Advocate and Co-Founder of the More Moments More Memories Foundation

Elizabeth H.Z. Thompson, Ph.D.

Sponsor Speaker

Elizabeth H.Z. Thompson, Ph.D.

Executive Vice President, Research and Development, Horizon Therapeutics

Ian Thompson

Sponsor Speaker

Ian Thompson

Senior Vice President and General Manager of U.S. Business Operations, Amgen

Tom Whitehead

Tom Whitehead

President & Co-founder, Emily Whitehead Foundation

Xin Zhang, Ph.D.

Xin Zhang, Ph.D.

Distinguished Professor of Engineering, Boston University

Rick Berke

Moderator

Rick Berke

Co-founder & Executive Editor, STAT

Elaine Chen

Moderator

Elaine Chen

Cardiovascular Disease Reporter, STAT

Isabella Cueto

Moderator

Isabella Cueto

Chronic Disease Reporter, STAT

Allison DeAngelis

Moderator

Allison DeAngelis

Biotech Startups and Venture Capital Reporter, STAT

Adam Feuerstein

Moderator

Adam Feuerstein

Senior Writer, Biotech, STAT

Erica Goode

Moderator

Erica Goode

Special Projects Editor, STAT

Matthew Herper

Moderator

Matthew Herper

Senior Writer, Medicine; Editorial Director of Events, STAT

Lizzy Lawrence

Moderator

Lizzy Lawrence

Medical Devices Reporter, STAT

Usha Lee McFarling

Moderator

Usha Lee McFarling

National Science Correspondent, STAT

Jesse McQuarters

Moderator

Jesse McQuarters

Branded Content Editor, STAT

Megan Molteni

Moderator

Megan Molteni

Science Writer, STAT

Mohana Ravindranath

Moderator

Mohana Ravindranath

Health Tech Correspondent, STAT

Ed Silverman

Moderator

Ed Silverman

Pharmalot Columnist, Senior Writer, STAT

Nicholas St. Fleur

Moderator

Nicholas St. Fleur

General Assignment Reporter; Associate Editorial Director of Events, STAT

Casey Ross

Moderator

Casey Ross

National Technology Correspondent, STAT

Megan Thielking

Moderator

Megan Thielking

Senior News Editor, STAT

Jonathan Wosen

Moderator

Jonathan Wosen

West Coast Biotech & Life Sciences Reporter, STAT

 

ATTEND

Registering for a group? Save 20% on each ticket when you buy 5 or more. When purchasing your ticket, add additional attendees and the discount will apply to your cart.

VIRTUAL

Day 2 Virtual Pass  $339

  • Live virtual access to the second day of the summit.
  • Networking abilities on the virtual platform to connect with fellow attendees and browse the virtual conference floor
  • Access to all recordings of the programming after the event
IN PERSON – BY APPLICATION ONLY

Attendee Pass  SOLD OUT

Only $1039 for STAT+ Subscribers

  • Two full in-person days of discussions and insights in San Francisco
  • Networking receptions and cocktail hours each evening to connect with fellow attendees and STAT’s award-winning journalists
  • Special access to the event recordings of the programming after the event

Attendee Pass Bundle  SOLD OUT

Best in-person deal for non-subscribers

  • Access all the benefits of the Attendee Pass PLUS a one-year subscription to STAT+ which includes
    • Subscriber-only newsletters and data tools
    • Subscriber-only discounts to STAT events, Reports, and other STAT products and initiatives
register now

STAT is committed to making this summit accessible. If our tickets are out of your price range, please feel free to email us at [email protected] to inquire about academic, nonprofit, government, and patient discounts.

Location

Join us in San Francisco

You can participate in the virtual programming from the comfort of your own computer or be a part of the program at the Commonwealth Club in San Francisco.

© Mapbox © OpenStreetMap

Agenda

Join us this May!

Agenda sessions, speakers, and timing are subject to change. Additional sessions will be announced in the coming weeks

May 3, 2023

7:30 a.m. PT

Registration Opens

90 minutes
Breakfast available for all summit attendees.

8:30 a.m. PT

Breakfast Session

30 min
Surprise featured speaker to be announced! Matthew Herper, senior writer, medicine; editorial director of events, STAT

9:15 a.m. PT

Welcome from STAT

5 min
Matthew Herper, senior writer, medicine; editorial director of events, STAT Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT

9:20 a.m. PT

Opening Remarks

5 min
Rick Berke, co-founder and executive editor, STAT

9:25 a.m PT

Living With a Cure

20 min
Emily Whitehead, co-founder of the Emily Whitehead Foundation Tom Whitehead, president & co-founder, Emily Whitehead Foundation Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

A decade ago, Emily Whitehead was the world’s first pediatric CART-T patient. Now, she is a healthy teenager, living cancer-free with doctors claiming she is effectively cured of the disease. Hear her story.

9:45 a.m. PT

Breakthroughs and Barriers: The Story of CAR-T

35 min
Carl June, M.D., director of the Center for Cellular Immunotherapies at the Perelman School of Medicine; director of the Parker Institute for Cancer Immunotherapy, University of Pennsylvania. Michel Sadelain, M.D., Ph.D., director, Center for Cellular Engineering, Memorial Sloan Kettering Cancer Center Christi Shaw, life science leader, patient advocate and co-founder of the More Moments More Memories Foundation Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

A decade ago, cell therapy seemed like the future of cancer therapy. Is that hope intact?

10:20 a.m. PT
Sponsor Session

Time is Life: How Pfizer Delivers Breakthroughs to Patients Faster

10 min
William Pao, M.D., Ph.D., chief development officer, executive vice president, Pfizer Jesse McQuarters, branded content editor, STAT (moderator)

Taking learnings from the company’s Covid-19 vaccine and treatment development programs, Pfizer is now applying the same urgency and ambition to other critical therapies and vaccines. Hear how the company plans to accelerate timelines to bring more breakthroughs to more patients faster.

10:30 a.m. PT

Do Viruses Cause Alzheimer’s?

30 min
Alberto Ascherio, M.D., Dr.PH, professor of epidemiology and nutrition, Harvard T.H. Chan School of Public Health Ruth Itzhaki, Ph.D., visiting professorial fellow, University of Oxford; professorial fellow emerita, University of Manchester Megan Molteni, science writer, STAT (moderator)

One of the biggest scientific advances of 2022 was the realization that multiple sclerosis may be caused by a common viral infection. What other diseases might actually be caused by viral infection? Two candidates: Alzheimer’s and ALS.

11:00 a.m. PT

COFFEE BREAK

30 min

11:30 a.m. PT

What Drug Patents Mean For Health Equity

25 min
Priti Krishtel, J.D., co-founder and co-executive director, Initiative for Medicines, Access & Knowledge (I-MAK); 2022 MacArthur Fellow Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

Priti Krishtel has become one of the most visible critics of the patent system and the pharmaceutical industry’s use of it. Hear how she believes changes to it could improve health equity and global health.

11:55 a.m. PT
Sponsor Session

The Future of Health at the Intersection of Human and Machine

10 min
Pratap Khedkar, Ph.D., CEO, ZS Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)

From alleviating physician burnout to detecting disease while it’s still treatable, the technology already exists to fix most of today’s health care ills — but only when paired with a human touch. AI adoption depends on trust — not trust in the algorithms but trust in the processes and policies that have validated them and in the health care provider they believe is invested in their health.

12:05 p.m. PT

Can AI Change Health Care?

25 min
Vinod Khosla, founder, Khosla Ventures Rick Berke, co-founder and executive editor, STAT (moderator)

Vinod Khosla, the co-founder of Sun Microsystems, is one of the biggest names in the history of venture capital. He wrote the first checks for OpenAI and Impossible. Now he believes that artificial intelligence is poised to change health care. Hear him describe his vision.

12:30 p.m. PT

LUNCH

90 min

2:00 p.m. PT
Sponsor Introduction

STAT Madness

55 min
Judges Panel: Rick Berke, co-founder and executive editor, STAT Erica Goode, special projects editor, STAT Taku Kambayashi, M.D., Ph.D., associate professor, Perelman School of Medicine at the University of Pennsylvania, and 2022 STAT Madness winner David Altshuler, M.D., Ph.D., executive vice president, global research and chief scientific officer, Vertex Pharmaceuticals Featured STAT Madness participants: Betty Kim, M.D., Ph.D., FRCSC, FAIMBE, professor of neurosurgery, MD Anderson Cancer Center – representing “Solid Tumor Targets” Xin Li, Ph.D., professor, department of molecular pathobiology, New York University – representing “Targeting Gums” Xin Zhang, Ph.D., distinguished professor of engineering, Boston University – representing “Boosting MRI”

STAT’s annual tournament for scientific innovation takes the stage! Three finalists in this year’s competition will present their discoveries to our panel of expert judges, and one will be selected as our “STAT Madness All-Star” by event attendees.

Sponsor Introduction
David Altshuler, M.D., Ph.D., executive vice president, global research and chief scientific officer, Vertex Pharmaceuticals
2:55 p.m. PT
Sponsor Session

The Evolution of Virtual Care

10 min
Vidya Raman-Tangella, chief medical officer, Teladoc Health Rick Berke, co-founder and executive editor, STAT (moderator)

The pandemic showed telehealth’s promise. Now patients and providers are bracing for a new regulatory landscape—and sought-after weight-loss drugs are fueling a fresh wave of scrutiny for virtual prescribing. Where do we go from here?

3:05 p.m. PT

Are Cancer-Detecting Blood Tests Ready for Prime Time?

30 min
Peter Bach, M.D., chief medical officer, Delfi Diagnostics Tina Clarke, Ph.D., MPH, VP, epidemiology and distinguished scientist, GRAIL LLC Gautam Kollu, chief executive officer, D2G Oncology Rita Redberg, M.D., MSc, cardiologist and professor of medicine at the University of California, San Francisco Lizzy Lawrence, medical devices reporter, STAT (moderator)

Researchers are finding ways to detect cancer early with a simple blood test using DNA sequencing. But how do we know when these tests are ready for wide use? Hear from experts on the balance between early detection and overtreatment.

3:35 p.m. PT

COFFEE BREAK

30 min

4:05 p.m. PT

Academia’s Mass Exodus

35 min
Joel Dudley, Ph.D., partner, Innovation Endeavors Donna Ginther, Ph.D., Roy A. Roberts & Regents Distinguished Professor of Economics, director, Institute for Policy & Social Research, University of Kansas Rayyan Gorashi, M.S., Ph.D. student, bioengineering at UC San Diego Sofie Kleppner, Ph.D., associate vice provost & associate dean for postdoctoral affairs, Stanford University Jonathan Wosen, Ph.D., West Coast biotech & life sciences reporter, STAT (moderator)

With early-career life scientists leaving the ivory tower at historic rates, the future of academic research is at stake. Does this system need to be tweaked or radically transformed?

4:40 p.m. PT
Sponsor Session

From Crisis to Opportunity: How Mobile Medicine Can Transform U.S. Health Care Delivery

5 min
Amit Phull, M.D., medical director and SVP of strategy, Doximity

The pandemic showed that mobile medicine can be harnessed to drive a paradigm shift in health care delivery and improve patient access to care. Hear how a time of crisis and uncertainty can provide a foundation for innovation and efficiency.

4:45 p.m. PT

Biotech After SVB

35 min
Vineeta Agarwala, M.D., Ph.D., general partner, Andreessen Horowitz Paul Hastings, chief executive officer and president, Nkarta Camille Samuels, partner, Venrock Surbhi Sarna, group partner, Y Combinator Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

The collapse of SVB and a sluggish IPO market spell uncertainty for biotech companies. Hear from a group of leading investors and startup founders about the state of the industry.

5:20 p.m. PT
Sponsor Speaker

Closing Remarks

5 min
Mark Bunnage, Ph.D., SVP, head of research, Vertex Pharmaceuticals

5:25 p.m. PT

Closing from STAT

5 min

5:30 p.m. PT

Networking Reception

90 min

Brought to you by 2023 STAT Madness sponsor, Vertex

7:00 p.m. PT
Sponsor Introduction

STAT Madness After Party

90 min

STAT is throwing a Mad party. Come network with STAT reporters and other brilliant Madness minds (or perhaps your toughest Madness rivals!) at the best tiki bar in San Francisco! This after party will take place offsite at Pagan Idol, located at: 375 Bush St, San Francisco, CA 94104. Open to all summit attendees. Brought to you by 2023 STAT Madness sponsor, Vertex.

Sponsor Introduction
Mark Bunnage, Ph.D., SVP, head of research, Vertex Pharmaceuticals

May 4, 2023

7:30 a.m. PT

Registration Opens

90 min
Breakfast available for all summit attendees.

9:00 a.m. PT
Sponsor Session

Opening Remarks

5 min
Gregory Rippon, M.D., vice president and chief medical partner, neurology, Genentech

9:05 a.m. PT

From Treating His Own Rare Disease to Treating Many

25 min
David Fajgenbaum, M.D., MSc, co-founder, Every Cure; director, CSTL, at the University of Pennsylvania Isabella Cueto, chronic disease reporter, STAT (moderator)

In 2014, David Fajgenbaum took a 25-year-old drug and sent the rare disease that was killing him into remission. Now he’s using artificial intelligence to do the same for other rare diseases. Hear about the progress his team is making.

9:30 a.m. PT

Verily’s New Direction

30 min
Amy Abernethy, M.D, Ph.D., president of product development and chief medical officer, Verily Stephen Gillett, chief executive officer, Verily Casey Ross, national technology correspondent, STAT (moderator)

Verily has long been known for its big ambitions to transform health care. Under a new leader, it is now channeling its investments into an effort to transform clinical trials for the 21st century. Hear what’s next.

10:00 a.m. PT
Sponsor Session

How Collaboration and Innovation Deliver For Patients

10 min
Sumita Bhatta, M.D., vice president, oncology, therapeutic area head, Amgen Ian Thompson, senior vice president and general manager of U.S. business operations, Amgen Jesse McQuarters, branded content editor, STAT (moderator)

The pace of innovations quickens daily. How should companies collaborate with patients and doctors to ensure the latest scientific knowledge about how to treat and prevent disease gets to the people who need it?

10:10 a.m. PT

The New Obesity Treatments: Benefits and Risks

30 min
Robert Lustig, M.D., MSL, emeritus professor of pediatrics, UCSF Jamy Ard, M.D., professor, Wake Forest School of Medicine; co-director, Weight Management Center, Atrium Health Wake Forest Baptist Elaine Chen, cardiovascular disease reporter, STAT (moderator)

For perhaps the first time ever new medicines are having a substantial impact on obesity. They promise to improve and maybe even save people’s lives. But do they also pose risks? How do we get the most out of these drugs?

10:40 a.m. PT

Ranking Drug Companies on Innovation and Invention

5 min
Jacqueline Barendregt, chief operating officer, IDEA Pharma

IDEA Pharma unveils the 12th annual edition of its ranking of the companies that do the best jobs creating medicines and bringing them to market.

10:45 a.m. PT

COFFEE BREAK

25 min

11:10 a.m. PT

Gilead’s Next Move

25 min
Daniel O’Day, chairman of the board of directors and chief executive officer, Gilead Sciences Adam Feuerstein, senior writer, biotech, STAT (moderator)

After several years of stumbles, the leader in HIV treatment has finally begun to establish a presence in cancer. Hear what’s next, about the company’s plan to deliver 10 transformative medicines by 2030, and about the state of biotech writ large.

11:35 a.m. PT
Sponsor Session

Advancing Brain Health

10 min
Noga Leviner, co-founder and CEO, Picnic Health Gregory Rippon, M.D., vice president and chief medical partner, neurology, Genentech Matthew Herper, senior writer, medicine, editorial director of events, STAT (moderator)

Considerable progress has been made in understanding brain health, but much remains to be done. Hear how collaborations in personalized health care and emerging health technology are helping to push the boundaries of scientific understanding.

11:45 a.m. PT

What Will Be The Biggest Company of 2050?

25 min
Robert Nelsen, co-founder and managing director, ARCH Venture Partners Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

Bob Nelsen has had a sometimes prophetic, always audacious view fo the future of biotechnology for decades. His latest bets have involved massive raises of capital and potentially crazy ideas about cell therapy, bodily regeneration, and manufacturing. Hear why he thinks his go-big-or-go-home model will continue to deliver.

12:10 p.m. PT

The Future of CRISPR

30 min
Jennifer Doudna, Ph.D., Nobel laureate, co-inventor of CRISPR Technology; president, Innovative Genomics Institute Megan Molteni, science writer, STAT (moderator)

As the gene editing technology hits the mainstream, CRISPR co-inventor Jennifer Doudna shares her predictions for what’s next and what still needs to be done to make this potentially life-changing technology more accessible. Are our predictions — good or bad — founded in reality?

12:40 p.m. PT

LUNCH

90 min

2:10 p.m. PT

AI in Health Care: What are the Risks?

35 min
Connor Landgraf, co-founder & CEO, Eko Health Suchi Saria, Ph.D., CEO & founder Bayesian Health, Inc; endowed chair & AI professor at Johns Hopkins Nigham Shah, MBBS, Ph.D., Chief Data Scientist, Stanford Healthcare Casey Ross, national technology correspondent, STAT (moderator)

The ability of AI models to answer medical questions and quickly summarize information has awakened the world to their potential. But they also commit grievous errors and make things up. So how can health care organizations reap the benefits while minimizing the risks? Let’s put aside the hype.

2:45 p.m. PT
Sponsor Session

How Patients Can Help Guide Scientific Innovation

10 min
Elizabeth H.Z. Thompson, Ph.D., executive vice president, research and development, Horizon Therapeutics Megan Thielking, senior news editor, STAT (moderator)

Understanding the patient experience can transform how a drug is developed. In Sjögrens disease, which causes dryness, this led Horizon scientists to pay attention to sexual health. In lupus, it meant recruiting patients with a diverse array of skin tones. Learn how listening to patients can mean better science.

2:55 p.m. PT

Patient Spotlight: Chronically Catherine

10 min
Catherine Ames, patient & patient advocate; writer of Daily Trojan’s “Chronically Catherine”

3:00 p.m. PT

Covid-19: What’s Next?

30 min
Kirsten Bibbins-Domingo, M.D., Ph.D., editor in chief, JAMA; professor of epidemiology and biostatistics, UCSF Peter Chin-Hong, M.D., associate dean and professor, UCSF School of Medicine Usha Lee McFarling, national science correspondent, STAT (moderator)

We may be done with Covid-19, but the virus isn’t yet done with us. Our experts have been go-to sources for trusted information throughout the pandemic. They’ll discuss what surprised them most about this massive public health crisis, how to navigate continuing uncertainty, and what they think lies ahead as the virus continues to surprise us.

3:30 p.m. PT

The Future of Psychiatry

30 min
Thomas Insel, M.D., executive chair and co-founder, Vanna Health; former director of the National Institute for Mental Health Mohana Ravindranath, Bay Area Correspondent, STAT (moderator)

As director of the National Institute of Mental Health, Thomas Insel articulated a bold vision: that understanding of psychiatric illness could be reduced to biology, not just an often qualitative examination of mental state. But he also had a front-row seat to the difficulty of using health tech to care for people with mental health disorders. Learn from his vision – and his experience.

4:00 p.m. PT

Closing from STAT

10 min

4:05 p.m. PT

STAT Breakthrough Summit Wrap Party

90 min

Open to all summit attendees! Sponsored by Real Chemistry.

Sponsors

A special thanks to our partners

Presenting Sponsor

STAT Madness Sponsor

Premium Sponsors

Supporting Sponsor

Contact

Stay in the loop

Join our email list

Sign up today for summit news and updates

Questions?

Email us any questions or concerns

[email protected]

Terms & Conditions